ASN
PBYI icon

Advisory Services Network’s Puma Biotechnology PBYI Stock Holding History

Advisory Services Network’s Portfolio PBYI Stock Details PBYI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-7,275
Closed -$75K – 2467
2020
Q4 		$75K Buy
7,275
+4,775
+191% +$48.3K ﹤0.01% 1469
2020
Q3 		$25K Buy
+2,500
New +$25.5K ﹤0.01% 1970
2018
Q4 		– Sell
-100
Closed -$5K – 2636
2018
Q3 		$5K Buy
+100
New +$4.82K ﹤0.01% 2082

Other funds holding PBYI

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Advisory Services Network's PBYI Position: Q1 2021 in Review

Advisory Services Network sold out of Puma Biotechnology (PBYI) in Q1 2021, closing a stake of 7,275 shares — an estimated $75K sold.

Advisory Services Network first reported a position in PBYI in Q3 2018 and held it in 3 quarters. The position peaked at $75K in Q4 2020. 118 funds tracked by Wall St. Rank hold PBYI as of Q1 2021.

  • Advisory Services Network reported no remaining Puma Biotechnology position as of Q1 2021 after selling out during the quarter.
  • Advisory Services Network sold 7,275 Puma Biotechnology shares in Q1 2021, an estimated $75K.
  • Advisory Services Network first reported a position in Puma Biotechnology in Q3 2018 and held it in 3 quarters.
  • Advisory Services Network's Puma Biotechnology position peaked at $75K in Q4 2020.
  • 118 funds tracked by Wall St. Rank held Puma Biotechnology as of Q1 2021.

Based on Advisory Services Network's 13F filing for Q1 2021, filed 24 May 2021.